Switching from sulphonylurea to a sodium-glucose cotransporter2 inhibitor in the fasting month of Ramadan is associated with a reduction in hypoglycaemia.

Published in:

Diabetes, Obesity & Metabolism, 2016, v. 18, n. 6, p. 628, doi. 10.1111/dom.12649

By:

• Wan Seman, W. J.;
• Kori, N.;
• Rajoo, S.;
• Othman, H.;
• Mohd Noor, N.;
• Wahab, N. A;
• Sukor, N.;
• Mustafa, N.;
• Kamaruddin, N. A.

Publication type:

Article